T-knife Therapeutics to Participate in Two Investor Conferences in March
SAN FRANCISCO and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer ...
LGI Homes Opens New Community in Riverside
New homes at Esplanade are priced starting at $460s with move-in ready opportunities available. To learn more or schedule a tour, interested buyers can call (877) 915-5617 ext 80 or visit LGIHomes.com ...